Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Pneumococcal Vaccine Market Evolve in Terms of Growth and Size by 2029?

In recent times, the market size of the pneumococcal vaccine has seen robust growth. The market, which is projected to increase from $8.94 billion in 2024 to $9.4 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 5.2%. Factors such as the discovery of streptococcus pneumoniae, public health apprehensions, initiatives for early vaccination, improvements in healthcare, and alterations in vaccine policy have contributed to its growth over the historical period.

Anticipations are high for a robust expansion in the pneumococcal vaccine market in the upcoming years. It is projected to reach “$11.9 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%.” Contributing factors for this growth forecast include the emergence of new pneumococcal strains, continuous innovation and research, immunization prioritization, increased access to vaccines, and an aging population. Major anticipated trends for the outlook period encompass the development of multivalent vaccines, immunization for high-risk groups, enhancing vaccine efficiency, educational and awareness initiatives, and a focus on infant immunization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp

What factors are expected to fuel Pneumococcal Vaccine market growth in the coming years?

The rise in pneumococcal contamination is anticipated to fuel the expansion of the pneumococcal vaccine market. Pneumococcal contamination, which can lead to illnesses such as pneumonia, bloodstream infections, ear infections, and sinus infections, is brought about by the Streptococcus pneumoniae, or pneumococcus bacteria. The pneumococcal vaccine works by triggering the body to create antibodies to fight off the pneumococcal bacteria, ultimately reducing or eliminating disease-bearing bacteria and toxins. This offers protection against numerous pneumococcal infections, especially in children, the elderly, and immunocompromised individuals. For instance, data from the US-based public health agency, the Center for Disease Control and Prevention, reported in January 2022, that Pneumococcal pneumonia leads to an estimated 150,000 hospitalizations annually in the United States, making up to 30% of adult community-acquired pneumonia. Thus, this escalating rate of pneumococcal contamination is a significant driver for the growth of the pneumococcal vaccine market.

The pneumococcal vaccine market covered in this report is segmented –

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

Subsegments:

1) By Prevnar 13: Pediatric Formulation, Adult Formulation

2) By Synflorix: Pediatric Formulation, Adult Formulation

3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes

4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

What Trends Are Currently Influencing Growth In The Pneumococcal Vaccine Market?

Leading corporations in the pneumococcal vaccine market are focusing on product innovation to enhance their market profitability. For instance, the US-based pharmaceutical firm, Merck & Co Inc., launched a new vaccine called V116 in July 2023. This vaccine is designed to target the eight unique serotypes of Streptococcus pneumoniae, which cause most cases of adult pneumococcal disease. V116 demonstrated superior immunogenicity across various serotypes in adults compared to its rivals. Moreover, it exhibited positive immune responses in both individuals with prior vaccination and those without. The U.S. Food and Drug Administration (FDA) has given it a breakthrough therapy status and is in the process of its Phase 3 development.

What Are The Most Active Companies In The Pneumococcal Vaccine Market Today?

Major companies operating in the pneumococcal vaccine market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, Inventprise LLC, Tergene Biotech Private Limited, PnuVax Incorporated, SK Bioscience Co Ltd

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Which Regional Markets Are Attracting The Most Investment In Pneumococcal Vaccine?

North America was the largest region in the pneumococcal vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11950&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model